Lifecore Biomedical
LFCR

Lifecore Biomedical (LFCR) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
Barrington ResearchMaintainedOutperform$6.50 from $6.00Jun 16, 2026
Barrington ResearchMaintainedOutperform$6.00 from $5.50Apr 29, 2026
Barrington ResearchMaintainedOutperform$5.50Mar 27, 2026
Barrington ResearchMaintainedOutperform$5.50Mar 24, 2026
Barrington ResearchUpgradedMarket Perform → Outperform$5.50Mar 17, 2026
KeybancInitiated CoverageSector WeightSep 4, 2025
William BlairInitiated CoverageOutperformMay 21, 2025
Stephens & Co.MaintainedEqual-Weight$6.00Jan 3, 2025
Craig-HallumMaintainedBuy$10.00 from $8.00Nov 22, 2024
Craig-HallumInitiated CoverageBuy$8.00Sep 5, 2024
Barrington ResearchDowngradedOutperform → Market PerformAug 28, 2024
Stephens & Co.MaintainedEqual-Weight$9.00 from $8.00Sep 1, 2023
Barrington ResearchMaintainedOutperform$10.00 from $11.00Sep 1, 2023
Barrington ResearchMaintainedOutperform$11.00 from $10.00Jun 2, 2023
Barrington ResearchMaintainedOutperform$10.00 from $8.00May 24, 2023

Frequently asked questions

  • What is the latest analyst rating on LFCR?

    On Jun 16, 2026, Barrington Research maintained Lifecore Biomedical at Outperform with a price target of $6.50.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.